This latest corporate clash has Alkermes working to beat back a challenge from H. Lundbeck for sleep disorder drug developer Avadel Pharmaceuticals.

Findings represent a detailed resource for future research that could lead to the development of new biomarkers and targeted therapeutics for T1D.

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...

The Fugaku supercomputer builds a highly detailed virtual mouse cortex with millions of neurons enabling unprecedented ...

The Virtual Cell Pharmacology Initiative (VCPI) is an open source platform designed to build a standardized framework for virtual cell models.

Novartis’ $23 billion investment in U.S.-based infrastructure over the next five years is designed to increase manufacturing capacity.

Microrobots could be precisely directed, under clinical conditions, by integrating systems for navigation, therapeutic ...

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...

New live-cell DNA damage sensor lets scientists watch repair unfold in real time, potentially opening doors for cancer and aging research.

In a study in IBD patients, scientists observed shifts in gut chemistry, among other changes, that could lead to new treatment strategies.

Model recapitulates key physiological features of native endosteal niches, and could aid in the study of blood formation in both healthy and diseased conditions.